Figure 1.
Precision medicine in oncology relies on biomarkers deriving from a diverse array of sources. Treatment decisions may be based on clinical characteristics of the patient and tumor (such as histopathology and cytopathology), genomic-variants (such as somatic mutations), or imaging features that describe a tumor tissue’s density, morphology, or texture.